The Dean's Video Messages

Dean Mary Klotman, MD, presents her annual State of the School address. The theme "Team Medicine in Action," highlighted some of the year's most impactful accomplishments in research, patient care, education, and equity.

A Conversation with Kafui Dzirasa, MD, PhD, the A. Eugene and Marie Washington Presidential Distinguished Professor, about his research into the underpinnings of mental illnesses such as depression and schizophrenia.

A Conversation with Eleanora Lad, MD, PhD, associate professor of ophthalmology, about the recent clinical trials that led to the first drug approved the FDA to treat a devastating eye disease called Geographic Atrophy.

A Conversation with Svati Shah, MD, about One DukeGEN, an initiative that uses genetics and advanced technologies to quickly translate scientific discovery into better clinical treatments.

Dean Klotman, talks with Raphael Valdivia, PhD, about the reasoning for changing the name of the Department of Immunology to the Department of Integrative Immunobiology.

Dean Klotman welcomes Julius Wilder, MD, PhD, Assistant Professor of Medicine, and Assistant Professor of Sociology, to discuss the rising rate of colon cancer in young adults, and what Duke is doing to help turn this trend around.

Dean Mary Klotman, MD, welcomes Barbara Hooper, the Founding Program Director and Division Chief of the Occupational Therapy Doctorate Program at Duke. They discuss the division's goals and some of the misconceptions about Occupational Therapy, and about what sets Duke’s program apart.

Dean Mary Klotman, MD, talks with Sarah Armstrong, MD, Duke Professor of Pediatrics and Chair of the American Academy of Pediatrics (AAP) Section on Obesity, about the AAP new guidelines for child and adolescent obesity.

Dean Mary Klotman, MD, talks with David Page, Professor and Chair of the Department of Biostatistics and Bioinformatics, about the advantages as well as the potential downsides of AI and Machine Learning, and about how the School of Medicine is working to maximize the opportunities and minimize the risks.

Dean Mary Klotman talks to Donald McDonnell, PhD, the Glaxo-Wellcome Distinguished Professor of Molecular Cancer Biology about the FDA-approved breakthrough drug for breast cancer developed in his Duke lab.